Venetoclax shows potential for R/R hairy cell leukemia

Published Date: 13 Mar 2023

Five out of six patients with relapsed or recurrent lymphoma responded to venetoclax alone or in combination with rituximab.

Read Full News

Latest News



Latest News


News All Time

Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Approved BTK Inhibitor Without Covalent Bond for CLL.

2.

An understudied type of breast cancer poses a lurking threat

3.

Depression risk higher among long-term breast cancer survivors than women without breast cancer history

4.

Coffee, Tea Tied to Lower Risk of Head and Neck Cancer

5.

Dr. Prerana S. Nesargi's message for Childhood Cancer Awareness Month 2023 is to increase understanding of pediatric oncology.


© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot